PSMC3 proteasome subunit variants are associated with neurodevelopmental delay and type I interferon production
Open accessThe DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Abstract
A critical step in preserving protein homeostasis is the recognition, binding, unfolding, and translocation of protein substrates by six AAA-ATPase proteasome subunits (ATPase-associated with various cellular activities) termed PSMC1-6, which are required for degradation of proteins by 26 S proteasomes. Here, we identified 15 de novo missense variants in the PSMC3 gene encoding the AAA-ATPase proteasome subunit PSMC3/Rpt5 in 23 unrelated heterozygous patients with an autosomal dominant form of neurodevelopmental delay and intellectual disability. Expression of PSMC3 variants in mouse neuronal cultures led to altered dendrite development, and deletion of the PSMC3 fly ortholog Rpt5 impaired reversal learning capabilities in fruit flies. Structural modeling as well as proteomic and transcriptomic analyses of T cells derived from patients with PSMC3 variants implicated the PSMC3 variants in proteasome dysfunction through disruption of substrate translocation, induction of proteotoxic stress, and alterations in proteins controlling developmental and innate immune programs. The proteostatic perturbations in T cells from patients with PSMC3 variants correlated with a dysregulation in type I interferon (IFN) signaling in these T cells, which could be blocked by inhibition of the intracellular stress sensor protein kinase R (PKR). These results suggest that proteotoxic stress activated PKR in patient-derived T cells, resulting in a type I IFN response. The potential relationship among proteosome dysfunction, type I IFN production, and neurodevelopment suggests new directions in our understanding of pathogenesis in some neurodevelopmental disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These variants affect the protein levels of proteasome subunits, or decreases their incorporation into 20S and 26S proteasome and also the assembly of 20S and 26S proteasome [18–20, 22, 23].”
From PSMC5 insufficiency and P320R mutation impair proteasome function (2024) · cites this paper as [19]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The inheritance pattern for these disorders can either be dominant, for the majority of variants in PSMD12 [Stankiewicz-Isidor syndrome, MIM: 617516]9,10, PSMC311 and PSMD1112, or recessive, as observed in cases involving PSMB1 [MIM: 620038]13 and PSMC3 [MIM: 619354]14 variants (Supplementary Fig. 1).”
From Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies (2025) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“However, Rpt6 KD caused significant defect in the ability to acquire novel association after initial training—a different behavior paradigm known as reversal learning (Tukey, p < 0.0001; N = 4; Fig. 3b), which is similar to what we previously reported in proteasome subunit gene PSMC3 KD models11.”
From Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies (2025) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, mutations in genes encoding proteasome subunits result in neurodevelopmental disorders, as exemplified by variants of genes encoding the 20S CP subunit PSMB1 (β1) [18] and the 19S RP subunits PSMC3 [19, 20] and PSMD12 [21–23].”
From PSMC5 insufficiency and P320R mutation impair proteasome function (2024) · cites this paper as [19]
The cited source says what the claim attributes to it.
In the citing paper
“Previous published work has shown that nonsense or missense variants of proteasome subunits PSMB1 [18], PSMC3 [19, 20], and PSMD12 [22, 23] are associated with neurodevelopmental disorders.”
From PSMC5 insufficiency and P320R mutation impair proteasome function (2024) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The mutational constraint spectrum quantified from variation in 141,456 humans
Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alföldi, J., Wang, Q., Collins, R. L., Laricchia, K. M., Ganna, A., Birnbaum, D. P., et al. (2020) · Nature · doi:10.1038/s41586-020-2308-7 · Cited by 9,434
The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences
Perez-Riverol, Y., Bai, J., Bandla, C., García-Seisdedos, D., Hewapathirana, S., Kamatchinathan, S., Kundu, D. J., Prakash, A., Frericks-Zipper, A., Eisenacher, M., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab1038 · Cited by 6,125
The neuropathological diagnosis of Alzheimer's disease
DeTure, M. A., & Dickson, D. W. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0333-5 · Cited by 3,329
Mechanisms Underlying Ubiquitination
Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,184 · cited 1×
“The proteasome is part of the ubiquitin-proteasome system (UPS), which counts numerous enzymes acting upstream of the proteasome (7, 8).”
BackgroundSequencing of 53,831 diverse genomes from the NHLBI TOPMed Program
Taliun, D., Harris, D. N., Kessler, M. D., Carlson, J., Szpiech, Z. A., Torres, R., Taliun, S. A. G., Corvelo, A., Gogarten, S. M., Kang, H. M., et al. (2021) · Nature · doi:10.1038/s41586-021-03205-y · Cited by 2,213
GeneMatcher: a matching tool for connecting investigators with an interest in the same gene.
Sobreira, N., Schiettecatte, F., Valle, D., & Hamosh, A. (2015) · Human Mutation · doi:10.1002/humu.22844 · Cited by 1,529
Classical conditioning and retention in normal and mutantDrosophila melanogaster
Tully, T., & Quinn, W. G. (1985) · Journal of Comparative Physiology A · doi:10.1007/bf01350033 · Cited by 1,183
Polyubiquitin chains: polymeric protein signals
Pickart, C. M., & Fushman, D. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.09.009 · Cited by 1,049
Meurs, E., Chong, K., Galabru, J., Thomas, N. S. B., Kerr, I. M., Williams, B. R. G., & Hovanessian, A. G. (1990) · Cell · doi:10.1016/0092-8674(90)90374-n · Cited by 1,017
Role of Rpn11 Metalloprotease in Deubiquitination and Degradation by the 26 S Proteasome
Verma, R., Aravind, L., Oania, R., McDonald, W. H., Yates, J. R., Koonin, E. V., & Deshaies, R. J. (2002) · Science · doi:10.1126/science.1075898 · Cited by 1,000
The logic of the 26S proteasome.
Collins, G. A., & Goldberg, A. L. (2017) · Cell · doi:10.1016/j.cell.2017.04.023 · Cited by 933 · cited 2×
“INTRODUCTION Proteasomes are large multi-protein complexes whose structure is adapted to the function of regulated protein degradation, thereby controlling many cellular processes (1, 2).”
BackgroundMethodAicardi–Goutières syndrome and the type I interferonopathies
Crow, Y. J., & Manel, N. (2015) · Nature Reviews Immunology · doi:10.1038/nri3850 · Cited by 925 · cited 4×
“The lack of systemic autoinflammation in patients with NDD/ID and PSMC3 variants mounting a constitutive type I IFN response may seem surprising at first sight, but it is not totally unexpected, because this inconsistency is found in other NDDs, including Aicardi-Goutières (75, 76) and Down syndrome (77, 78).”
BackgroundInfluentialPhipson, B., Lee, S., Majewski, I. J., Alexander, W. S., & Smyth, G. K. (2016) · The Annals of Applied Statistics · doi:10.1214/16-aoas920 · Cited by 917
The proteasome: overview of structure and functions
TANAKA, K. (2009) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.85.12 · Cited by 862
Identifying facial phenotypes of genetic disorders using deep learning
Gurovich, Y., Hanani, Y., Bar, O., Nadav, G., Fleischer, N., Gelbman, D., Basel-Salmon, L., Krawitz, P. M., Kamphausen, S. B., Zenker, M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0279-0 · Cited by 739
Self-citationBack to the Future with Ubiquitin
Pickart, C. M. (2004) · Cell · doi:10.1016/s0092-8674(03)01074-2 · Cited by 697
Microglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy
Muzio, L., Viotti, A., & Martino, G. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.742065 · Cited by 581
Immunoproteasomes Preserve Protein Homeostasis upon Interferon-Induced Oxidative Stress
Seifert, U., Bialy, L. P., Ebstein, F., Bech-Otschir, D., Voigt, A., Schröter, F., Prozorovski, T., Lange, N., Steffen, J., Rieger, M., et al. (2010) · Cell · doi:10.1016/j.cell.2010.07.036 · Cited by 551
Self-citationProteasome Inhibitors: An Expanding Army Attacking a Unique Target
Kisselev, A. F., van der Linden, W. A., & Overkleeft, H. S. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.01.003 · Cited by 527
Radhakrishnan, S. K., Lee, C. S., Young, P., Beskow, A., Chan, J. Y., & Deshaies, R. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.02.029 · Cited by 526
Smith, D. M., Chang, S.-C., Park, S., Finley, D., Cheng, Y., & Goldberg, A. L. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.033 · Cited by 521
Swainson, R., Rogers, R. D., Sahakian, B. J., Summers, B. A., Polkey, C. E., & Robbins, T. W. (2000) · Neuropsychologia · doi:10.1016/s0028-3932(99)00103-7 · Cited by 494
The type I interferonopathies: 10 years on
Crow, Y. J., & Stetson, D. B. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00633-9 · Cited by 489
PACT, a protein activator of the interferon-induced protein kinase, PKR
Patel, R. C. (1998) · The EMBO Journal · doi:10.1093/emboj/17.15.4379 · Cited by 457
Reduced orbitofrontal-striatal activity on a reversal learning task in obsessive-compulsive disorder
Remijnse, P. L., Nielen, M. M. A., van Balkom, A. J. L. M., Cath, D. C., van Oppen, P., Uylings, H. B. M., & Veltman, D. J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.11.1225 · Cited by 408
Liu, Y., Ramot, Y., Torrelo, A., Paller, A. S., Si, N., Babay, S., Kim, P. W., Sheikh, A., Lee, C. R., Chen, Y., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33368 · Cited by 406
Mitochondria as central regulators of neural stem cell fate and cognitive function
Khacho, M., Harris, R., & Slack, R. S. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0091-3 · Cited by 399 · cited 1×
“This observation supports the growing consensus that mitochondrial dysfunction is a key determinant of the pathogenesis of neurodevelopment (89) and the cause of interferonopathies (90).”
BackgroundMarzec, M., Eletto, D., & Argon, Y. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.10.013 · Cited by 390
Proteasomal Degradation Is Transcriptionally Controlled by TCF11 via an ERAD-Dependent Feedback Loop
Steffen, J., Seeger, M., Koch, A., & Krüger, E. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.012 · Cited by 369
Self-citationFinger, E. C., Marsh, A. A., Mitchell, D. G., Reid, M. E., Sims, C., Budhani, S., Kosson, D. S., Chen, G., Towbin, K. E., Leibenluft, E., et al. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.5.586 · Cited by 365
Trisomy 21 consistently activates the interferon response
Sullivan, K. D., Lewis, H. C., Hill, A. A., Pandey, A., Jackson, L. P., Cabral, J. M., Smith, K. P., Liggett, L. A., Gomez, E. B., Galbraith, M. D., et al. (2016) · eLife · doi:10.7554/elife.16220 · Cited by 362
Brehm, A., Liu, Y., Sheikh, A., Marrero, B., Omoyinmi, E., Zhou, Q., Montealegre, G., Biancotto, A., Reinhardt, A., Almeida de Jesus, A., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81260 · Cited by 344
Self-citationZhu, K., Dunner, K., & McConkey, D. J. (2010) · Oncogene · doi:10.1038/onc.2009.343 · Cited by 338 · cited 1×
“Because proteasome dysfunction typically engages stress responses involving compensatory mechanisms such as autophagy (87), ISR, and UPR (24, 88), we reasoned that the type I IFN response detected in patients with PSMC3 variants might be triggered by sustained activation of either one of these pathways.”
BackgroundAgarwal, A. K., Xing, C., DeMartino, G. N., Mizrachi, D., Hernandez, M. D., Sousa, A. B., Martínez de Villarreal, L., dos Santos, H. G., & Garg, A. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.10.031 · Cited by 335
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome
Dong, Y., Zhang, S., Wu, Z., Li, X., Wang, W. L., Zhu, Y., Stoilova-McPhie, S., Lu, Y., Finley, D., & Mao, Y. (2019) · Nature · doi:10.1038/s41586-018-0736-4 · Cited by 328
Arima, K., Kinoshita, A., Mishima, H., Kanazawa, N., Kaneko, T., Mizushima, T., Ichinose, K., Nakamura, H., Tsujino, A., Kawakami, A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106015108 · Cited by 327
Bedford, L., Hay, D., Devoy, A., Paine, S., Powe, D. G., Seth, R., Gray, T., Topham, I., Fone, K., Rezvani, N., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2218-08.2008 · Cited by 327 · cited 1×
“This notion is in line with previous reports showing that conditional inactivation of other 19S proteasome subunits (Psmc2/Rpt2 and Psmc4/Rpt3) in mice results in severe neuronal phenotypes with features of neurodegeneration and locomotor dysfunction (55, 56).”
ResultA mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans
Kitamura, A., Maekawa, Y., Uehara, H., Izumi, K., Kawachi, I., Nishizawa, M., Toyoshima, Y., Takahashi, H., Standley, D. M., Tanaka, K., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58414 · Cited by 308
Reversal learning as a measure of impulsive and compulsive behavior in addictions
Izquierdo, A., & Jentsch, J. D. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2579-7 · Cited by 295
Protein homeostasis: live long, won't prosper
Toyama, B. H., & Hetzer, M. W. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3496 · Cited by 283
DNA damage-induced type I interferon promotes senescence and inhibits stem cell function
Yu, Q., Katlinskaya, Y. V., Carbone, C. J., Zhao, B., Katlinski, K. V., Zheng, H., Guha, M., Li, N., Chen, Q., Yang, T., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.069 · Cited by 260
Gal-Ben-Ari, S., Barrera, I., Ehrlich, M., & Rosenblum, K. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00480 · Cited by 254
Gates, Channels, and Switches: Elements of the Proteasome Machine
Finley, D., Chen, X., & Walters, K. J. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.10.009 · Cited by 251
Proteasomes: Machines for All Reasons
DeMartino, G. N., & Gillette, T. G. (2007) · Cell · doi:10.1016/j.cell.2007.05.007 · Cited by 239
Strehl, B., Seifert, U., Krüger, E., Heink, S., Kuckelkorn, U., & Kloetzel, P. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00308.x · Cited by 234
Self-citationGestaltMatcher facilitates rare disease matching using facial phenotype descriptors
Hsieh, T.-C., Bar-Haim, A., Moosa, S., Ehmke, N., Gripp, K. W., Pantel, J. T., Danyel, M., Mensah, M. A., Horn, D., Rosnev, S., et al. (2022) · Nature Genetics · doi:10.1038/s41588-021-01010-x · Cited by 233
Self-citationTrisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation
Sullivan, K. D., Evans, D., Pandey, A., Hraha, T. H., Smith, K. P., Markham, N., Rachubinski, A. L., Wolter-Warmerdam, K., Hickey, F., Espinosa, J. M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13858-3 · Cited by 228 · cited 1×
“This is particularly well exemplified in patients with Down syndrome who, similar to patients with NDD/ID and PSMC3 dominant variants, exhibit a constitutive activation of type I IFN signaling (79, 80).”
BackgroundUSP18 lack in microglia causes destructive interferonopathy of the mouse brain
Goldmann, T., Zeller, N., Raasch, J., Kierdorf, K., Frenzel, K., Ketscher, L., Basters, A., Staszewski, O., Brendecke, S. M., Spiess, A., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201490791 · Cited by 223
Benkirane, M. (1997) · The EMBO Journal · doi:10.1093/emboj/16.3.611 · Cited by 220
Leeson, V. C., Robbins, T. W., Matheson, E., Hutton, S. B., Ron, M. A., Barnes, T. R. E., & Joyce, E. M. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.05.016 · Cited by 219
Akwa, Y., Hassett, D. E., Eloranta, M., Sandberg, K., Masliah, E., Powell, H. C., Whitton, J. L., Bloom, F. E., & Campbell, I. L. (1998) · PubMed · Cited by 215
Excess protein synthesis in Drosophila fragile X mutants impairs long-term memory
Bolduc, F. V., Bell, K., Cox, H., Broadie, K. S., & Tully, T. (2008) · Nature Neuroscience · doi:10.1038/nn.2175 · Cited by 211
Self-citationAssessment of Type I Interferon Signaling in Pediatric Inflammatory Disease
Rice, G. I., Melki, I., Frémond, M.-L., Briggs, T. A., Rodero, M. P., Kitabayashi, N., Oojageer, A., Bader-Meunier, B., Belot, A., Bodemer, C., et al. (2017) · Journal of Clinical Immunology · doi:10.1007/s10875-016-0359-1 · Cited by 209
Akwa, Y., Hassett, D. E., Eloranta, M.-L., Sandberg, K., Masliah, E., Powell, H., Whitton, J. L., Bloom, F. E., & Campbell, I. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.5016 · Cited by 202
Structure and Function of the Protein Kinase R
Sadler, A. J., & Williams, B. R. G. (2007) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-71329-6_13 · Cited by 201
Tashiro, Y., Urushitani, M., Inoue, H., Koike, M., Uchiyama, Y., Komatsu, M., Tanaka, K., Yamazaki, M., Abe, M., Misawa, H., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.417600 · Cited by 194
Brief report: Cognitive flexibility in autism spectrum disorders: A quantitative review
Leung, R. C., & Zakzanis, K. K. (2014) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-014-2136-4 · Cited by 192
De Novo Mutations in Protein Kinase Genes CAMK2A and CAMK2B Cause Intellectual Disability
Küry, S., van Woerden, G. M., Besnard, T., Proietti Onori, M., Latypova, X., Towne, M. C., Cho, M. T., Prescott, T. E., Ploeg, M. A., Sanders, S., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.10.003 · Cited by 185
Self-citationCampbell, I. L., Krucker, T., Steffensen, S., Akwa, Y., Powell, H. C., Lane, T., Carr, D. J., Gold, L. H., Henriksen, S. J., & Siggins, G. R. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01328-1 · Cited by 182
Crow, Y., & Livingston, J. (2016) · Neuropediatrics · doi:10.1055/s-0036-1592307 · Cited by 180
Araya, P., Waugh, K. A., Sullivan, K. D., Núñez, N. G., Roselli, E., Smith, K. P., Granrath, R. E., Rachubinski, A. L., Enriquez Estrada, B., Butcher, E. T., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908129116 · Cited by 179 · cited 1×
“The lack of systemic autoinflammation in patients with NDD/ID and PSMC3 variants mounting a constitutive type I IFN response may seem surprising at first sight, but it is not totally unexpected, because this inconsistency is found in other NDDs, including Aicardi-Goutières (75, 76) and Down syndrome (77, 78).”
BackgroundThe Structure, Activation and Signaling of IRE1 and Its Role in Determining Cell Fate
Siwecka, N., Rozpędek-Kamińska, W., Wawrzynkiewicz, A., Pytel, D., Diehl, J. A., & Majsterek, I. (2021) · Biomedicines · doi:10.3390/biomedicines9020156 · Cited by 172
Poli, M. C., Ebstein, F., Nicholas, S. K., de Guzman, M. M., Forbes, L. R., Chinn, I. K., Mace, E. M., Vogel, T. P., Carisey, A. F., Benavides, F., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.04.010 · Cited by 168
Self-citationEmerging roles of immunoproteasomes beyond MHC class I antigen processing
Ebstein, F., Kloetzel, P., Krüger, E., & Seifert, U. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0938-0 · Cited by 163
Self-citationTomko, R. J., Funakoshi, M., Schneider, K., Wang, J., & Hochstrasser, M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.02.035 · Cited by 153
Waugh, K. A., Araya, P., Pandey, A., Jordan, K. R., Smith, K. P., Granrath, R. E., Khanal, S., Butcher, E. T., Estrada, B. E., Rachubinski, A. L., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.038 · Cited by 150 · cited 1×
“The lack of systemic autoinflammation in patients with NDD/ID and PSMC3 variants mounting a constitutive type I IFN response may seem surprising at first sight, but it is not totally unexpected, because this inconsistency is found in other NDDs, including Aicardi-Goutières (75, 76) and Down syndrome (77, 78).”
BackgroundHausrat, T. J., Muhia, M., Gerrow, K., Thomas, P., Hirdes, W., Tsukita, S., Heisler, F. F., Herich, L., Dubroqua, S., Breiden, P., et al. (2015) · Nature Communications · doi:10.1038/ncomms7872 · Cited by 138
MobiDetails: online DNA variants interpretation
Baux, D., Goethem, C. V., Ardouin, O., Guignard, T., Bergougnoux, A., Koenig, M., & Roux, A. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-00755-z · Cited by 128
Ribosomal proteins produced in excess are degraded by the ubiquitin–proteasome system
Sung, M.-K., Reitsma, J. M., Sweredoski, M. J., Hess, S., & Deshaies, R. J. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-05-0290 · Cited by 126 · cited 1×
“Consistent with this notion, proteasome inhibition has been recently shown to result in the aggregation of ubiquitin-modified ribosomal proteins (72).”
BackgroundThe proteasome: molecular machinery and pathophysiological roles
Tanaka, K., Mizushima, T., & Saeki, Y. (2012) · bchm · doi:10.1515/hsz-2011-0285 · Cited by 125
Oti, M., Huynen, M. A., & Brunner, H. G. (2008) · Trends in Genetics · doi:10.1016/j.tig.2007.12.005 · Cited by 124
Kavanagh, D., McGlasson, S. L., Jury, A., Williams, J., Scolding, N. J., Bellamy, C. O. C., Günther, C., Ritchie, D. L., Gale, D. P., Kanwar, Y. S., et al. (2016) · Blood · doi:10.1182/blood-2016-05-715987 · Cited by 122
N-glycanase NGLY1 regulates mitochondrial homeostasis and inflammation through NRF1
Yang, K., Huang, R., Fujihira, H., Suzuki, T., & Yan, N. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20180783 · Cited by 121 · cited 1×
“This observation supports the growing consensus that mitochondrial dysfunction is a key determinant of the pathogenesis of neurodevelopment (89) and the cause of interferonopathies (90).”
BackgroundThe Unfolded Protein Response Triggers Selective mRNA Release from the Endoplasmic Reticulum
Reid, D. W., Chen, Q., Tay, A. S.-L., Shenolikar, S., & Nicchitta, C. V. (2014) · Cell · doi:10.1016/j.cell.2014.08.012 · Cited by 120
de Jesus, A. A., Brehm, A., VanTries, R., Pillet, P., Parentelli, A.-S., Montealegre Sanchez, G. A., Deng, Z., Paut, I. K., Goldbach-Mansky, R., & Krüger, E. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.12.1012 · Cited by 114
Self-citationGoslin, K., & Banker, G. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.4.1319 · Cited by 113
Küry, S., Besnard, T., Ebstein, F., Khan, T. N., Gambin, T., Douglas, J., Bacino, C. A., Craigen, W. J., Sanders, S. J., Lehmann, A., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.01.003 · Cited by 110
Self-citationRibosomal biogenesis as an emerging target of neurodevelopmental pathologies
Hetman, M., & Slomnicki, L. P. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14576 · Cited by 110
Immunoproteasomes at the interface of innate and adaptive immune responses: two faces of one enzyme
Krüger, E., & Kloetzel, P. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.01.005 · Cited by 107
Self-citationThe impact of PKR activation: from neurodegeneration to cancer
Marchal, J. A., Lopez, G. J., Peran, M., Comino, A., Delgado, J. R., García‐García, J. A., Conde, V., Aranda, F. M., Rivas, C., Esteban, M., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-248294 · Cited by 104
Fonteneau, J., Larsson, M., Somersan, S., Sanders, C. J., Münz, C., Kwok, W. W., Bhardwaj, N., & Jotereau, F. (2001) · Journal of Immunological Methods · doi:10.1016/s0022-1759(01)00477-x · Cited by 99
Type I Interferonopathies in Children: An Overview
d’Angelo, D. M., Filippo, P. D., Breda, L., & Chiarelli, F. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.631329 · Cited by 99
Genetic Dissection of Memory Formation in Drosophila melanogaster
Tully, T., Boynton, S., Brandes, C., Dura, J. M., Mihalek, R., Preat, T., & Villella, A. (1990) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1990.055.01.022 · Cited by 97 · cited 1×
“This may be assessed by evaluating reversal learning performance, a process that was initially identified in Drosophila models (60) and whose dysfunction has been associated with the pathogenesis of various neuropsychiatric disorders (61– 65).”
MethodThe Temporal Dynamics of Arc Expression Regulate Cognitive Flexibility
Wall, M. J., Collins, D. R., Chery, S. L., Allen, Z. D., Pastuzyn, E. D., George, A. J., Nikolova, V. D., Moy, S. S., Philpot, B. D., Shepherd, J. D., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.05.012 · Cited by 96
Knaus, A., Pantel, J. T., Pendziwiat, M., Hajjir, N., Zhao, M., Hsieh, T., Schubach, M., Gurovich, Y., Fleischer, N., Jäger, M., et al. (2018) · Genome Medicine · doi:10.1186/s13073-017-0510-5 · Cited by 89
Self-citationMammalian proteasome subtypes: Their diversity in structure and function
Dahlmann, B. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.12.012 · Cited by 88
The integrated stress response and proteotoxicity in cancer therapy
McConkey, D. J. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.11.047 · Cited by 85 · cited 1×
“Proteotoxic stress is known to induce the unfolded protein response and integrated stress response (UPR and ISR, respectively) (24, 47).”
BackgroundDysfunction in protein clearance by the proteasome: impact on autoinflammatory diseases
Brehm, A., & Krüger, E. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0486-4 · Cited by 79
Self-citationEbstein, F., Lange, N., Urban, S., Seifert, U., Krüger, E., & Kloetzel, P. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.10.023 · Cited by 79
Self-citationEbstein, F., Poli Harlowe, M. C., Studencka-Turski, M., & Krüger, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02756 · Cited by 79 · cited 13×
“To address this point, we inhibited key players of the UPR and/ or ISR, including PKR, IRE1, and GADD34 (24), by treating patients’ T cells with the C16, 4μ8C, or Guanabenz inhibitors, respectively.”
BackgroundInfluentialSelf-citationProteasome Modulates Positive and Negative Translational Regulators in Long-Term Synaptic Plasticity
Dong, C., Bach, S. V., Haynes, K. A., & Hegde, A. N. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3291-13.2014 · Cited by 73 · cited 2×
“Although proteasomes have been shown to regulate long-term potentiation (LTP) (66, 67), their involvement in reversal learning has not previously been shown.”
BackgroundA tale of two proteins: PACT and PKR and their roles in inflammation
Chukwurah, E., Farabaugh, K. T., Guan, B., Ramakrishnan, P., & Hatzoglou, M. (2021) · The FEBS Journal · doi:10.1111/febs.15691 · Cited by 72
Type I interferon response impairs differentiation potential of pluripotent stem cells
Eggenberger, J., Blanco-Melo, D., Panis, M., Brennand, K., & tenOever, B. R. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812449116 · Cited by 69 · cited 1×
“To what extent type I IFN actively contributes to the pathogenesis of these disorders remains to be fully determined, although a growing body of evidence supports the notion that IFN has detrimental effects on CNS function (81–84) as well as stem cell function and differentiation (85, 86).”
BackgroundThe role of GFAP and vimentin in learning and memory
Wilhelmsson, U., Pozo-Rodrigálvarez, A., Kalm, M., de Pablo, Y., Widestrand, Å., Pekna, M., & Pekny, M. (2019) · Biological Chemistry · doi:10.1515/hsz-2019-0199 · Cited by 68
PSMB10, the last immunoproteasome gene missing for PRAAS
Sarrabay, G., Méchin, D., Salhi, A., Boursier, G., Rittore, C., Crow, Y., Rice, G., Tran, T.-A., Cezar, R., Duffy, D., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.11.024 · Cited by 65
Kröll‐Hermi, A., Ebstein, F., Stoetzel, C., Geoffroy, V., Schaefer, E., Scheidecker, S., Bär, S., Takamiya, M., Kawakami, K., Zieba, B. A., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911861 · Cited by 65
Self-citationEnhanced differential expression statistics for data-independent acquisition proteomics
Suomi, T., & Elo, L. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-05949-y · Cited by 59
Medina, L. M. P., Becker, A., Michalik, S., Yedavally, H., Raineri, E. J. M., Hildebrandt, P., Salazar, M. G., Surmann, K., Pförtner, H., Mekonnen, S. A., et al. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.001138 · Cited by 59
Self-citationGreene, E. R., Dong, K. C., & Martin, A. (2019) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2019.10.004 · Cited by 53 · cited 1×
“The lid contains eight additional non-ATPase subunits, such as Rpn3, Rpn5-9, Rpn12, and Rpn15, which serve as scaffolds for binding of other subunits (15, 16) and the deubiquitinating enzyme Rpn11 (encoded by PSMD14) SC I ENCE TRANSLAT IONAL MED IC INE | R E S EARCH ART I C L E”
BackgroundSynaptic Cytoskeletal Plasticity in the Prefrontal Cortex Following Psychostimulant Exposure
DePoy, L. M., & Gourley, S. L. (2015) · Traffic · doi:10.1111/tra.12295 · Cited by 52
Flexibility in young people with autism spectrum disorders on a card sort task
Reed, P., Watts, H., & Truzoli, R. (2013) · Autism · doi:10.1177/1362361311409599 · Cited by 50
Marbach, F., Rustad, C. F., Riess, A., Đukić, D., Hsieh, T.-C., Jobani, I., Prescott, T., Bevot, A., Erger, F., Houge, G., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.02.021 · Cited by 50
Self-citationThe HA tag is cleaved and loses immunoreactivity during apoptosis
Schembri, L., Dalibart, R., Tomasello, M. F., Legembre, P., Ichas, F., & Giorgi, F. D. (2007) · Nature Methods · doi:10.1038/nmeth0207-107 · Cited by 47 · cited 1×
“One potential explanation for this observation implies a partial destruction of the HA epitope, as previously described (44).”
Studencka‐Turski, M., Çetin, G., Junker, H., Ebstein, F., & Krüger, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02900 · Cited by 46 · cited 10×
“To address this point, we inhibited key players of the UPR and/ or ISR, including PKR, IRE1, and GADD34 (24), by treating patients’ T cells with the C16, 4μ8C, or Guanabenz inhibitors, respectively.”
BackgroundInfluentialSelf-citationAnsar, M., Ebstein, F., Özkoç, H., Paracha, S. A., Iwaszkiewicz, J., Gesemann, M., Zoete, V., Ranza, E., Santoni, F. A., Sarwar, M. T., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa032 · Cited by 44
Self-citationAhmed, M. M., Johnson, N. R., Boyd, T. D., Coughlan, C. M., Chial, H. J., & Potter, H. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.718426 · Cited by 43
Mechanisms of protein homeostasis in health, aging and disease
Goloubinoff, P. (2016) · Swiss Medical Weekly · doi:10.4414/smw.2016.14306 · Cited by 38
Priming of the cGAS-STING-TBK1 Pathway Enhances LPS-Induced Release of Type I Interferons
Tesser, A., Piperno, G. M., Pin, A., Piscianz, E., Boz, V., Benvenuti, F., & Tommasini, A. (2021) · Cells · doi:10.3390/cells10040785 · Cited by 38 · cited 1×
“In addition, the potential implication of mitophagy-mediated mitochondrial DNA in this process was investigated by treating the cells with H-151, an inhibitor of the cytosolic DNA sensor STING (stimulator of IFN genes protein) (54).”
MethodGreene, E. R., Goodall, E. A., de la Peña, A. H., Matyskiela, M. E., Lander, G. C., & Martin, A. (2019) · eLife · doi:10.7554/elife.49806 · Cited by 35 · cited 1×
“The lid contains eight additional non-ATPase subunits, such as Rpn3, Rpn5-9, Rpn12, and Rpn15, which serve as scaffolds for binding of other subunits (15, 16) and the deubiquitinating enzyme Rpn11 (encoded by PSMD14) SC I ENCE TRANSLAT IONAL MED IC INE | R E S EARCH ART I C L E”
BackgroundHaploinsufficiency of PSMD12 Causes Proteasome Dysfunction and Subclinical Autoinflammation
Yan, K., Zhang, J., Lee, P. Y., Tao, P., Wang, J., Wang, S., Zhou, Q., & Dong, M. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42070 · Cited by 33 · cited 2×
“Although it is well established that proteasome loss-of-function variants cause interferonopathies in patients with PRAAS (27– 33), it was only recently that pathogenic mutations in the 19S regulatory particle subunit PSMD12/Rpn5 were reported to engage constitutive type I IFN signaling in patients with this NDD disor…”
BackgroundResultBourque, D. K., Hartley, T., Nikkel, S. M., Pohl, D., Tétreault, M., Kernohan, K. D., & Dyment, D. A. (2017) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2017.10.011 · Cited by 30
Wu, T. G., Rose, W., Albrecht, T., Knutson, E. P., König, R., Perdigão, J. R., Nguyen, A. P. A., & Fleischmann, W. R. (2007) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2007.0039 · Cited by 29
Histone degradation by the proteasome regulates chromatin and cellular plasticity
Shmueli, M. D., Sheban, D., Eisenberg‐Lerner, A., & Merbl, Y. (2021) · FEBS Journal · doi:10.1111/febs.15903 · Cited by 26
Stankiewicz-Isidor syndrome: expanding the clinical and molecular phenotype
Isidor, B., Ebstein, F., Hurst, A., Vincent, M., Bader, I., Rudy, N. L., Cogne, B., Mayr, J., Brehm, A., Bupp, C., et al. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2021.09.005 · Cited by 24
Self-citationShin, E., Seifert, U., Urban, S., Truong, K.-T., Feinstone, S. M., Rice, C. M., Kloetzel, P. M., & Rehermann, B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.supp.44.39 · Cited by 22
Autoinflammation: Interferonopathies and Other Autoinflammatory Diseases
Savic, S., Coe, J., & Laws, P. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.07.189 · Cited by 16
Kostyszyn, B., Cowburn, R. F., Seiger, Å., Kjældgaard, A., & Sundström, E. (2004) · Developmental Brain Research · doi:10.1016/j.devbrainres.2004.04.005 · Cited by 12
Smolen, P. D., Baxter, D. A., & Byrne, J. H. (2018) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2018.08.026 · Cited by 3
Cited by
GestaltMatcher facilitates rare disease matching using facial phenotype descriptors
Hsieh, T.-C., Bar-Haim, A., Moosa, S., Ehmke, N., Gripp, K. W., Pantel, J. T., Danyel, M., Mensah, M. A., Horn, D., Rosnev, S., et al. (2022) · Nature Genetics · doi:10.1038/s41588-021-01010-x · Cited by 233
Self-citationSchmidt, A., Danyel, M., Grundmann, K., Brunet, T., Klinkhammer, H., Hsieh, T., Engels, H., Peters, S., Knaus, A., Moosa, S., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01836-1 · Cited by 79
“After the end of the study, two more candidate genes transitioned to the group of DGGs due to additional phenotypic, functional and statistical evidence became available 32,34 .”
Self-citationGoldbach‐Mansky, R. T., Alehashemi, S., & de Jesus, A. A. (2024) · Nature Reviews Rheumatology · doi:10.1038/s41584-024-01184-8 · Cited by 54
“…found increased PKR phosphorylation, an increase in an interferon response genes signature and compensatory upregulation of autophagy and mitophagy 196 ; however, a compartmentalized role of type I interferon in modifying clinical features of NDD and autism spectrum disorder in the CNS has not…”
Papendorf, J. J., Ebstein, F., Alehashemi, S., Piotto, D. G. P., Kozlova, A., Terreri, M. T., Shcherbina, A., Rastegar, A., Rodrigues, M., Pereira, R., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1190104 · Cited by 38
“These results indicate that, despite different organ manifestations, the molecular mechanisms driving the clinically different disease manifestations are similar but may act in a tissue specific manner (43).”
BackgroundSelf-citationLesmann, H., Hustinx, A., Moosa, S., Klinkhammer, H., Marchi, E. J., Caro, P., Abdelrazek, I. M., Pantel, J. T., ten Hagen, M., Thong, M., et al. (2023) · medRxiv · doi:10.1101/2023.06.06.23290887 · Cited by 39
“For example, Ebstein et al. showed that facial dysmorphism is more heterogeneous among their PSMC3 patient cohort, but more similarities were found in patients with identical variants 22 .”
Self-citation
Metadata
- Authors
- Ebstein, F., Küry, S., Most, V., Rosenfelt, C., Scott-Boyer, M.-P., van Woerden, G. M., Besnard, T., Papendorf, J. J., Studencka-Turski, M., Wang, T., Hsieh, T.-C., Golnik, R., Baldridge, D., Forster, C., de Konink, C., Teurlings, S. M. W., Vignard, V., van Jaarsveld, R. H., Ades, L., Cogné, B., Mignot, C., Deb, W., Jongmans, M. C. J., Cole, F. S., van den Boogaard, M.-J. H., Wambach, J. A., Wegner, D. J., Yang, S., Hannig, V., Brault, J. A., Zadeh, N., Bennetts, B., Keren, B., Gélineau, A.-C., Powis, Z., Towne, M., Bachman, K., Seeley, A., Beck, A. E., Morrison, J., Westman, R., Averill, K., Brunet, T., Haasters, J., Carter, M. T., Osmond, M., Wheeler, P. G., Forzano, F., Mohammed, S., Trakadis, Y., Accogli, A., Harrison, R., Guo, Y., Hakonarson, H., Rondeau, S., Baujat, G., Barcia, G., Feichtinger, R. G., Mayr, J. A., Preisel, M., Laumonnier, F., Kallinich, T., Knaus, A., Isidor, B., Krawitz, P., Völker, U., Hammer, E., Droit, A., Eichler, E. E., Elgersma, Y., Hildebrand, P. W., Bolduc, F., Krüger, E., & Bézieau, S.
- Affiliations
- Universitätsmedizin Greifswald (DE)
- Centre National de la Recherche Scientifique (FR)
- Leipzig University (DE)
- University of Alberta (CA)
- Research Center of Quebec CHU-Université Laval, Québec, QC PQ G1E6W2, Canada.
- Department of Neuroscience, Erasmus University Medical Center, 3015 CN, Rotterdam, Netherlands.
- Institut für Medizinische Biochemie und Molekularbiologie (IMBM), Universitätsmedizin Greifswald, Ferdinand-Sauerbruch-Straße, 17475 Greifswald, Germany.
- University of Washington (US)
- University of Bonn (DE)
- University Hospital in Halle (DE)
- Washington University in St. Louis (US)
- GeneDx, 207 Perry Parkway, Gaithersburg, MD 20877, USA.
- Erasmus MC (NL)
- Department of Genetics, University Medical Center Utrecht, 3508 AB, Utrecht, Netherlands.
- Department of Clinical Genetics, Children’s Hospital at Westmead, Locked Bag 4001, Westmead, NSW 2145, Australia.
- University Medical Center Utrecht (NL)
- Vanderbilt University Medical Center (US)
- Children's Hospital of Orange County (US)
- The University of Sydney (AU)
- Assistance Publique – Hôpitaux de Paris (FR)
- Ambry Genetics (United States) (US)
- Geisinger Health System (US)
- Seattle Children's Hospital (US)
- Orlando Health (US)
- St. Luke's Clinic (US)
- The University of Texas at San Antonio Health Science Center (US)
- Helmholtz Munich (DE)
- LMU Klinikum (DE)
- University of Ottawa (CA)
- Guy's Hospital (GB)
- McGill University Health Centre (CA)
- Nottingham University Hospitals NHS Trust (GB)
- Children's Hospital of Philadelphia (US)
- Hôpital Necker-Enfants Malades (FR)
- Paracelsus Medical University (AT)
- Université de Tours (FR)
- Leibniz Association (DE)
- Université Laval (CA)
- Howard Hughes Medical Institute (US)
- Humboldt-Universität zu Berlin (DE)
- Nantes Université, CHU Nantes, Service de Génétique Médicale, 44000 Nantes, France.
- Corresponding author
- Ebstein, Frédéric
- Küry, Sébastien
- Bolduc, François
- Krüger, Elke
- ORCID
- Ebstein, Frédéric
- Küry, Sébastien
- Most, Victoria
- Rosenfelt, Cory
- van Woerden, Geeske M.
- Besnard, Thomas
- Studencka-Turski, Maja
- Wang, Tianyun
- Hsieh, Tzung-Chien
- Golnik, Richard
- Baldridge, Dustin
- de Konink, Charlotte
- Teurlings, Selina M.W.
- Vignard, Virginie
- Cogné, Benjamin
- Mignot, Cyril
- Deb, Wallid
- Jongmans, Marjolijn C.J.
- Cole, F. Sessions
- van den Boogaard, Marie-José H.
- Wambach, Jennifer A.
- Wegner, Daniel J.
- Yang, Sandra
- Bennetts, Bruce
- Keren, Boris
- Powis, Zöe
- Towne, Meghan
- Bachman, Kristine
- Seeley, Andrea
- Beck, Anita E.
- Morrison, Jennifer
- Averill, Kelly
- Brunet, Theresa
- Haasters, Judith
- Carter, Melissa T.
- Osmond, Matthew
- Wheeler, Patricia G.
- Forzano, Francesca
- Mohammed, Shehla
- Trakadis, Yannis
- Accogli, Andrea
- Harrison, Rachel
- Guo, Yiran
- Hakonarson, Hakon
- Rondeau, Sophie
- Baujat, Geneviève
- Barcia, Giulia
- Feichtinger, René Günther
- Mayr, Johannes Adalbert
- Preisel, Martin
- Laumonnier, Frédéric
- Kallinich, Tilmann
- Knaus, Alexej
- Isidor, Bertrand
- Krawitz, Peter
- Völker, Uwe
- Hammer, Elke
- Droit, Arnaud
- Eichler, Evan E.
- Elgersma, Ype
- Hildebrand, Peter W.
- Bolduc, François
- Krüger, Elke
- Bézieau, Stéphane
- Venue
- Science Translational Medicine
- Published
- 2023-05-31
- Volume
- 15
- Issue
- 698
- Pages
- eabo3189-eabo3189
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC10506367
- OpenAlex
- W4378802689
- Cited by
- 36
- References
- 118
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 13 · 2023: 7
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- other-oa
- Locations
- Science Translational Medicine (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- HAL (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Funders
- Genome Canada (OGI‐147)
- Wellcome Trust
- Ontario Genomics
- Simons Foundation Autism Research Initiative (608045)
- E-Rare
- Ontario Genomics Institute (OGI‐147)
- Genome British Columbia
- Deutsche Forschungsgemeinschaft (Project B4), SFBTR167)
- Agence Nationale de la Recherche (ANR-21-CE17-0005, ANR-22-RAR4-0001)
- Austrian Science Fund (I4695-B)
- Genome Alberta
- National Institutes of Health
- Canadian Institutes of Health Research
- Fundamental Research Funds for the Central Universities (BMU2022RCZX038)
- National Institute of Mental Health (R01MH101221)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Keywords
- proteasome subunits, AAA+ ATPase, neurodevelopmental delay, intellectual disability, de novo missense variant, proteotoxic stress, proteostasis, dendrite formation, T cells, type I interferon signaling, PKR, innate immunity, proteasome dysfunction, reversal learning
- MeSH terms
- ATPases Associated with Diverse Cellular Activities, Adenosine Triphosphatases, Animals, Drosophila melanogaster, Humans, Interferon Type I, Endopeptidases, Gene Expression, Drosophila Proteins, Proteomics, Proteasome Endopeptidase Complex, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.